Litcius/Paper detail

The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis

Kota Araki, Rie Kinoshita, Nahoko Tomonobu, Yuma Gohara, Shuta Tomida, Yuta Takahashi, Satoru Senoo, Akihiko Taniguchi, Junko Itano, Ken-ichi Yamamoto, Hitoshi Murata, Ken Suzawa, Kazuhiko Shien, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Kouichi Ichimura, Masahiro Nishibori, Nobuaki Miyahara, Shinichi Toyooka, Masakiyo Sakaguchi

2020Journal of Molecular Medicine67 citationsDOI

Topics & Concepts

Pulmonary fibrosisMolecular medicineMedicineIdiopathic pulmonary fibrosisFibrosisHuman geneticsPathologyLungInternal medicineBiologyGeneticsGeneCell cycleCancerS100 Proteins and AnnexinsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational exposure and asthma
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis | Litcius